 Lack correlation histologic findings response metastatic breast cancer retrospective analysis prognostic role histologic findings response chemotherapy survival patients metastatic breast cancer Histologic material available patients metastatic breast cancer M.D Anderson Cancer Center Chemotherapy doxorubicin cyclophosphamide similar drugs tamoxifen Maintenance cyclophosphamide methotrexate years cumulative doxorubicin dose histologic distribution infiltrating ductal carcinoma invasive lobular mixed histology mucinous signet ring tubular papillary individual histologic types patients ductal nonductal groups Baseline patient characteristics age performance status estrogen-receptor status hormone response disease extent levels alkaline phosphatase bilirubin lactate dehydrogenase similar groups patients nonductal histology metastatic sites patients hemoglobin mg/dl albumin mg/dl nonductal group patients factors impact results response rate complete partial ductal group response rate complete partial nonductal group time initiation chemotherapy progression identical months groups Survival initiation chemotherapy different months ductal months nonductal study authors histologic findings bearing patient response metastatic breast cancer